Multiple myeloma, also known as Kahler’s disease, is a cancer of plasma cells. These are white blood cells found in bone marrow that produce antibodies to fight infections. In multiple myeloma, abnormal plasma cells multiply uncontrollably, producing excessive immunoglobulin proteins that accumulate in the blood and organs, leading to organ damage. These cells crowd out normal blood cells and release substances that damage bones, causing lytic lesions. Over time, the disease leads to weakened bones, anemia, kidney issues, and immune suppression
Early symptoms may be absent or vague. Common signs include: Treatment duration varies by patient age, health, and cancer stage. It may last 3 months to over a year depending on response. Q: What is the survival rate for Multiple Myeloma? A: The 5-year survival rate is approximately 49%, but this varies based on several factors
India's JCI and NABH-accredited hospitals offer international-standard outcomes at a fraction of US and UK prices, with shorter waiting times, English-speaking care teams, and dedicated international patient departments.
| Country | Estimated Cost |
|---|---|
| United States | $150,000 |
| United Kingdom | $70,000 |
| India via Medvalley | $5,000 – $25,000 |
BLK-Max Super Speciality Hospital
New Delhi · JCI, NABH
Fortis Escorts Heart Institute
New Delhi ·
Indraprastha Apollo Hospital
New Delhi ·
Manipal Hospital Dwarka
New Delhi ·
Max Super Speciality Hospital Patparganj
New Delhi · NABH, NABL
Max Super Speciality Hospital Saket
New Delhi ·
Apollo Hospital Bengaluru
Bengaluru ·
Aster CMI Hospital
Bengaluru ·
HCG Hospital Bengaluru
Bengaluru ·
Manipal Hospital Old Airport Road
Bengaluru ·
Apollo Cancer Institute Chennai
Chennai ·
Apollo Hospital Chennai
Chennai ·
